Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial

Autor: Alessandro Rambaldi, Carola Boccomini, Atto Billio, Francesco Angrilli, Roberto Passera, Marco Ladetto, Francesco Zallio, Gianpietro Semenzato, Liliana Devizzi, Fabio Ciceri, Barbara Mantoan, Fausto Rossini, Alessandra Dondi, Alessandra Tucci, Fabio Benedetti, Caterina Stelitano, Delia Rota-Scalabrini, Valerio Zoli, Paolo Corradini, Riccardo Bruna, Corrado Tarella, Maurizio Musso, Franco Narni, Caterina Patti, Guido Gini, Claudia Castellino, Tommasina Perrone, Anna Maria Barbui, Francesco Lanza, Anna Marina Liberati, Guido Parvis, Francesco Di Raimondo, Alessandro Massimo Gianni, Alessandro Pulsoni, Angela Gueli
Přispěvatelé: Bruna R., Benedetti F., Boccomini C., Patti C., Barbui A. M., Pulsoni A., Musso M., Liberati A. M., Gini G., Castellino C., Rossini F., Ciceri F., Rota-Scalabrini D., Stelitano C., Di Raimondo F., Tucci A., Devizzi L., Zoli V., Zallio F., Narni F., Dondi A., Parvis G., Semenzato G., Lanza F., Perrone T., Angrilli F., Billio A., Gueli A., Mantoan B., Rambaldi A., Massimo Gianni A., Corradini P., Passera R., Ladetto M., Tarella C., Bruna, R., Benedetti, F., Boccomini, C., Patti, C., Barbui, A. M., Pulsoni, A., Musso, M., Liberati, A. M., Gini, G., Castellino, C., Rossini, F., Ciceri, F., Rota-Scalabrini, D., Stelitano, C., Di Raimondo, F., Tucci, A., Devizzi, L., Zoli, V., Zallio, F., Narni, F., Dondi, A., Parvis, G., Semenzato, G., Lanza, F., Perrone, T., Angrilli, F., Billio, A., Gueli, A., Mantoan, B., Rambaldi, A., Massimo Gianni, A., Corradini, P., Passera, R., Ladetto, M., Tarella, C.
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Male
Oncology
Lymphoma
medicine.medical_treatment
advanced-stage follicular lymphoma
Follicular lymphoma
Kaplan-Meier Estimate
law.invention
0302 clinical medicine
Cancer immunotherapy
Randomized controlled trial
Recurrence
immune system diseases
law
hemic and lymphatic diseases
Antineoplastic Combined Chemotherapy Protocols
Prospective cohort study
Lymphoma
Follicular

non-Hodgkin lymphoma
Remission Induction
Hematology
Middle Aged
Prognosis
Combined Modality Therapy
Treatment Outcome
Italy
chemoimmunotherapy
Female
Rituximab
Adult
Follow-Up Studies
Humans
Neoplasm Staging
Proportional Hazards Models
Young Adult
medicine.drug
medicine.medical_specialty
Sudden death
Article
NO
03 medical and health sciences
Lymphoma
therapy
clinical trial

Internal medicine
medicine
Cancer staging
Chemotherapy
business.industry
Follicular
medicine.disease
business
030215 immunology
Zdroj: Haematologica
Popis: A prospective trial conducted in the period 2000-2005 showed no survival advantage for high-dose chemotherapy with rituximab and autograft (R-HDS) versus conventional chemotherapy with rituximab (CHOP-R) as first-line therapy in 134 high-risk follicular lymphoma patients aged
Databáze: OpenAIRE